Pharmaceutical executive Parker Rudderham wants to tap local farms in effort to expand production.

A Cape Breton pharmaceutical executive is urging local farmers to take a chance on a new crop as the first run of his new company's hemp seed oil hits the shelves of European stores.

Highland Hemp Manufacturing and Exports produced 22,000 bottles of cold-pressed oil that was grown, processed and bottled on Cape Breton. The nutty flavoured product contains Omega-3 and Omega-6 oils and is intended for food, such as salads.

"The market for hemp is a huge market — and we got to get into this whole hog," said CEO Parker Rudderham, who is also president of Pharmacy Wholesale Services Inc.

Throughout the holiday giving season, we're encouraged to support worthy charities with our dollars.

But making donations can be difficult, or even impossible, for people who struggle financially. Luckily, giving back in meaningful ways doesn't have to break the bank.

Giving Tuesday, which always falls on the Tuesday after Thanksgiving in the U.S., is a national day of giving that kicks off the charitable season. And even though it coincides with the holiday shopping season — which can already be a strain on families with tight budgets — you can make a difference without emptying your wallet.

For Giving Tuesday this year, check out these no-cost ways to do some good.

The cannabis industry has been trending lower since the election with market sentiment in negative territory following the appointment of Alabama Senator Jeff Sessions as United States Attorney General.

The recent pullback has been associated with weaker-than-average trading volume and we are monitoring this trend on an industry-wide and a company-by-company basis. The lighter trading volume has had a significant affect on cannabis stocks as the average stock spread has expanded (difference between a stock’s buy and sell price) and we continue to monitor this trend closely.

Canopy Growth Corporation ("Canopy Growth" or the "Company") (CGC.TO)  today announced that it has entered into an agreement to acquire MedCann GmbH Pharma and Nutraceuticals (MedCann), a German-based pharmaceutical distributor who has successfully placed Tweed-branded cannabis strains in German pharmacies.

MedCann has proven its ability to navigate the complex regulatory environment for cannabis importation and distribution in Germany . With a highly experienced leadership team, led by Dr. Pierre Debs , it has established itself as a leading cannabis importer and distributor within Germany where the cannabis industry still relies solely on imported products.

Zurich residents with illness may have a card that allows them to acquire cannabis more easily.

The medical cannabis user should be able to obtain it more easily in the city of Zurich. The City Council of Zurich followed up a postulate of the Greens by 80 votes to 36 last Wednesday .

It is already possible for patients to calm their pain by means of cannabis products. However, they require an authorization from the Federal Office of Public Health (FOPH).

But the procedure to obtain the latter is so complicated that many patients go and supply themselves with cannabis by illegal means, explained the Zurich Greens. Criminalizing these people makes no sense.

“We’re very proud to be hosting medical cannabis research,” Dr Václav Trojan, head of the Faculty of Agronomy of Mendel University in the Czech Republic, told a group of representatives from some of Europe’s most exciting cannabis organizations who had convened for a three day seminar arranged by the International Cannabis and Cannabinoids Institute (ICCI) and run by Americans for Safe Access (ASA).

Mendel University, located in the city of Brno, has been researching medical cannabis since the government made it legal to do so around two and a half years ago. The first European seminar of Patient Focused Certification (PFC) was held there last week.

Cannabis is hugely popular. 182m people use cannabis across the world and, with this level of exposure, the way cannabis is regulated matters. As does the evidence of risks and benefits to health which underpins regulation.

Sometimes saying nothing is as telling as saying something. Silence can suggest retaining the status quo. The World Health Organisation (WHO) has been silent about the international regulatory controls on cannabis since its inception in 1935. The past 80 years have brought dramatic advances in scientific knowledge about cannabis, so it is odd that it has not provided updated advice about its legal status. 

The Federal Agency for Medicines and Health Products (FAMHP) has received anapplication to allow the establishment of a large R&D facility to perform large-scale research into medicinal cannabis in the town of Kinrooi in the provence of Limburg. If this research facility can be established, it will generate approximately 500 to 800 new jobs.

The suppression of spasticity in MS patients or pain relief to cancer: the impact of medical cannabis in the year 2016 is undisputed. "Still, much more research is absolutely needed," says Joris Vanvinckenroye, founder of Royal Doctors.

South Tyrol (Alto Adige in Italian) is an autonomous province in Italy with a population more than 500,000. Recently, in Bolzano, the capital city of the region, the libertarians issued a motion to legalize cannabis use, however, it was rejected by the South Tyrolian State Parliament.

Marking another milestone on the road to ending cannabis prohibition in the Netherlands, a sizeable majority of Dutch Prime Minister Mark Rutte’s VVD party have voted to support what they’re calling “smart regulation” of cannabis. Following a vote at a Nov. 19 party converence in Noordwijkerhout, the VVD’s platform going into the general elections next spring will now include the intention “to redesign the entire domain surrounding soft drugs.”